RECURSION PHARMACEUTICALS, INC. Annual Operating Margin in % from 2019 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2024.
  • Recursion Pharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2024 was -814 %, a 3.66% decline year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2024 was -814 %, a 3.66% decline from 2023.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2023 was -785 %, a 27.3% decline from 2022.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2022 was -617 %, a 65.7% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -814 -28.8 -3.66% Jan 1, 2024 Dec 31, 2024
2023 -785 -169 -27.3% Jan 1, 2023 Dec 31, 2023
2022 -617 +1.18K +65.7% Jan 1, 2022 Dec 31, 2022
2021 -1.8K +340 +15.9% Jan 1, 2021 Dec 31, 2021
2020 -2.14K +557 +20.7% Jan 1, 2020 Dec 31, 2020
2019 -2.69K Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.